GlassScriptPhysician profile
Luke J Hunter
NPI 1457772774
$2,459.86
in general payments reported to CMS, 2019-2025
23 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $414 · 2021: $679 · 2022: $198 · 2023: $447 · 2024: $340 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853 · Education: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.21 |
| Education | $315.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $315.00 | 2023-2025 | Dr Comfort |
| Musculoskeletal Transplant Foundation INC. | $285.33 | 2020-2021 | |
| Stryker Corporation | $268.85 | 2020-2021 | |
| Rikco International, LLC | $192.00 | 2021 | |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Paratek Pharmaceuticals, INC. | $159.55 | 2021-2025 | Nuzyra |
| Trilliant Surgical LLC. | $140.43 | 2020 | |
| Organogenesis INC. | $138.56 | 2021 | |
| Convatec INC. | $134.37 | 2024-2025 | |
| Bioventus LLC | $121.78 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Biowound Solutions, INC. | $108.64 | 2025 | Bio-Connekt |
| Kerecis Limited | $105.48 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $65.82 | 2022-2025 | |
| Trice Medical, INC. | $62.09 | 2022 | |
| Smith+Nephew, INC. | $34.80 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25.29 | 2024 | Krystexxa |
| Nevro Corp. | $24.19 | 2023 | Senza |
| Triad Life Sciences INC. | $22.55 | 2022 | |
| Treace Medical Concepts, INC. | $19.46 | 2023 | |
| Grt US Holding, INC. | $18.89 | 2022 | |
| Horizon Therapeutics Plc | $18.51 | 2020 | |
| Solventum Corporation | $16.64 | 2024 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Kowa Pharmaceuticals America, INC. | $14.63 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.